Braftm1.1Tumg
Targeted Allele Detail
|
|
| Symbol: |
Braftm1.1Tumg |
| Name: |
B-Raf proto-oncogene, serine/threonine kinase; targeted mutation 1.1, Yoko Aoki |
| MGI ID: |
MGI:7488140 |
| Synonyms: |
Braftm1.1(Q241R)Tumg |
| Gene: |
Braf Location: Chr6:39580171-39702397 bp, - strand Genetic Position: Chr6, 18.43 cM
|
| Alliance: |
Braftm1.1Tumg page
|
|
| Germline Transmission: |
Earliest citation of germline transmission:
J:216228
|
| Parent Cell Line: |
Not Specified (ES Cell)
|
| Strain of Origin: |
C57BL/6J
|
|
| Allele Type: |
|
Targeted (Not Applicable) |
| Mutations: |
|
Insertion, Nucleotide substitutions
|
| |
|
Mutation details: A PGK-Neo-STOP cassette flanked by loxP sites was inserted in intron 6 and a glutamine to arginine substitution at amino acid 241 (Q241R) was inserted into exon 7 via homologous recombination. The mutant transcript is expressed after cre-mediated recombination.
(J:216228)
|
|
|
| Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
| Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
| Carrying any Braf Mutation: |
62 strains or lines available
|
|
| Original: |
J:216228 Inoue S, et al., New BRAF knockin mice provide a pathogenetic mechanism of developmental defects and a therapeutic approach in cardio-facio-cutaneous syndrome. Hum Mol Genet. 2014 Dec 15;23(24):6553-66 |
| All: |
1 reference(s) |
|